Skip to main content

Rheumatoid Arthritis

    Virtual EULAR 2020 Round Up
    In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include: SELECT-CHOICE study. ABA vs. UPA in…
    Autoinflammatory/Still's Disease Panel - EULAR2020

    Drs. Olga Petryna, Petros Efthimiou, Apostolos Kontzias and Jack Cush discuss autoinflammatory highlights from the Virtual EULAR 2020 meeting June 3-6

    These were my top abstracts from Thursday, 4th of June at EULAR 2020: Long Delays in Denosumab Increase Fracture Risk (SAT0453).  A UK population based study looked at risk of fracture in…
    These were my top abstracts from Thursday, 4th of June at EULAR 2020: Voclosporin Effective in Lupus Nephritis (OP0277). Voclosporin is a calcineurin inhibitor that has performed well in an…
    Every time a big scientific meeting ends I ask myself a question: how is it going to affect the way I treat my patients? This year the question pertains to management of axial…
    Here is my top-five from day one at EULAR: Merkel PA, et al. (OP0011) Avacopan as effective as steroids in ANCA Associated Vasculitis (AAV) – 330 patient RCT where AAV was treated with either with…
    SELECT-Choice: UPA vs ABA in RA

    Dr. Jack Cush from EULAR2020 Virtual Conference

    OP0151

    Updated EULAR Recommendations for RA Management

    Dr. Kathryn Dao from EULAR2020 Virtual Conference

    Your #RA patients in low disease or remission, do you maintain, reduce or stop DMARDs #EULAR2020
    3 years 9 months ago
    Your #RA patients in low disease or remission, do you maintain, reduce or stop DMARDs #EULAR2020